ABSTRACT
INTRODUCTION
diabetes. [25] There is evidence to suggest that altered vitamin D and calcium homeostasis also play a role in the development of T2DM; and recently, Knekt et al. reported that high vitamin D status provides protection against type 2 diabetes. [26] [27] In recent years, several polymorphisms, such as BsmI and FokI, have been described in the VDR genes that are able to alter the activity of VDR protein. [28] Some of the other polymorphisms in the VDR gene identiÞ ed by allelic variation in restriction enzyme sites are Tru9I, TaqI, EcoRV and ApaI. [29] All these are located between exons 8 and 9 except that FokI is in exon 2. FokI polymorphism has been shown to have functional role in trascriptional activation of VDR gene. [30] However, the genetic background of the disease still remains unclear. Although these Þ ndings suggest that the VDR gene is a novel candidate gene contributing to susceptibility to T2DM [ Table 1 ], there are no data on association of VDR gene polymorphism with T2DM in the north Indian population. In our present work, we studied the FokI, BsmI and TaqI restriction enzyme polymorphisms of the VDR gene in patients with T2DM in a north Indian population.
MATERIALS AND METHODS

Subject selection
The current study was carried out after obtaining prior approval from the institutional ethical committee of Chhatrapati Sahuji Maharaj Medical University (CSMMU), Lucknow, India. Patients (n= 100) with type 2 diabetes attending the Diabetes Clinic in the outpatient department of CSMMU, Lucknow, were enrolled for the present study.
populations. [1] [2] [3] [4] [5] [6] [7] [8] [9] An association study of candidate genes, viz., fatty acid binding protein 2 (FABP2), uncoupling protein type 1 gene (UCP1), protein phosphatase type 1 (PP1G), β3 adrenergic receptor (β3AR), VDR, was carried out on T2DM patients in a migrant Indian population as well by Boullus-Sanchis et al. [10] Genome-wide association studies have led to the identiÞ cation of several single nucleotide polymorphisms in genes such as CDKAL1, CDKN2B, HHEX/IDE, IGF2BP2, KCNJ11, SLC30A8, TCF2, TCF7L2 and WFS1. [11] Several genes were studied but only a handful showed conÞ rmed association, such as resistin, alpha-endosulfine, calpain10, peroxisome proliferators-activated receptor-gamma 2 (PPARγ-2), abundant transcript 1 gene (apM1), TCF7L2, insulin-like growth factor-binding protein 5 (IGFBP5), to name a few. [9, [12] [13] [14] [15] [16] [17] [18] [19] Earlier studies on genetic polymorphisms in T2DM candidate genes were carried out among south Indians, in addition to those in the VDR gene. [20] [21] [22] VDR is a member of the steroid/thyroid hormone receptor family. [23] It is known that vitamin D and especially its activated metabolite 1,25-dihydroxyvitamin D3 (1,25D3) are involved in controlling the normal functions of the endocrine pancreas, particularly insulin secretion; and the action of vitamin D is mediated through binding to its nuclear receptor (VDR). [24] Vitamin D and its receptor complex play the role of a transcription factor in regulating the β-cell insulin secretion. Vitamin-D deÞ ciency has been shown to impair insulin synthesis and secretion in humans and in animal models of diabetes, which suggests it has a role in the development of type 2 Screening and management of patients were done as per American Diabetes Association guidelines. [31] A questionnaire was used to record clinical history of patients, family history of diabetes and associated complications such as hypertension, etc.
A total of 160 age-and sex-matched normal healthy controls were enrolled for the study from among the healthy staff members of the institute and the university. They were screened with standard oral glucose tolerance test. Subjects having a history of coronary artery disease and other complications were not included in the control group.
DNA extraction and genotyping
After obtaining an informed consent, 5 mL of blood sample was collected in anticoagulant and plain vials from patients of both the groups. DNA was extracted from the blood samples [ Table 2 ]. [32] [33] PCR-RFLP was used to identify the genotypic pattern of VDR family.
In order to improve the genotyping quality and validation, 20% of samples were re-genotyped by other laboratory personnel, and results were found to be reproducible with no discrepancy in genotyping. Genotyping of 10% randomly selected samples was confirmed by DNA sequencing. [36] and exon 9 (TaqI) BsmI 293 NA S Germany Ortlepp et al [37] ApaI, BsmI, TaqI 242 71.7 + 8.6 NS San Diego, Oh et al [38] BsmI 49 57 (29-77) NS Hungry Speer et al [23] FokI, BsmI, ApaI and TaqI 267 50.0 ± 9.2 NS Poland Cyganek et al [39] ApaI, BsmI and TaqI 164 45.9 ± 10.3 S (ApaI) Bangladeshi Asians Hitman et al [22] NS (BsmI and TaqI 
Statistical analysis
Allele frequencies, genotype frequencies and carriage rates of the alleles in all the groups were compared by using Fisher's exact test. The Hardy-Weinberg equilibrium at individual loci was assessed by χ 2 statistics using SPSS software (version 15.0), and clinical association was calculated by paired t test. All P values were two sided, and differences were considered statistically significant for P< 0.05. Odds ratio (OR) at 95% conÞ dence interval (CI) was determined to describe the strength of association by logistic regression model. Allele frequency was calculated as the number of occurrences of the test allele in the population divided by the total number of alleles. Carriage rate was calculated as the number of individuals carrying at least one copy of test allele divided by the total number of individuals.
RESULTS
Clinical characteristics of the patients are summarized in Table 3 Table 4 . We did not observe any signiÞ cant difference in VDR (FokI, BsmI and TaqI) genotypes between patient and control groups (P= 0.119, 0.428 and 0.416, respectively). Genotypes of each VDR marker were in HardyWeinberg equilibrium in each group separately and in the total of 100 T2DM patients. In addition, we also compared the VDR (FokI, BsmI and TaqI) genotypes with different clinical parameters of T2DM but could not obtain association of any of the parameters except age (P= 0.002) and waist-hip ratio (P= 0.013) with VDR TaqI genotypes [ 
DISCUSSION
Allelic differences in the VDR gene may contribute to the genetic predisposition to certain diseases. As vitamin D modulates insulin secretion, it is feasible that genetic variants of the VDR gene may contribute to the development of T2DM. Since patients with T2DM exhibit subtle alterations in glucose metabolism long before onset of the disease, genetic factors contributing to its pathogenesis or development could be detected early in the disease process. [34] Our study revealed significant association of age (P= 0.002) and waist-hip ratio (P= 0.013) with TaqI genotypes of VDR gene polymorphism. This may indicate the association of VDR polymorphism with both modiÞ able and nonmodiÞ able risk factors of diabetes.
Our investigation showed the nonsigniÞ cant association between VDR (FokI, BsmI and TaqI) genotypes and diabetes risk in the north VDR GENOTYPE AND TYPE 2 DIABETES Two studies have reported link between VDR polymorphism and diabetes risk -one in Caucasian subjects, for BsmI site; and the other in Bangladeshi Asians, for ApaI site. [23] However, our study, like the one in Polish population, showed no association between VDR FokI, ApaI, BsmI and TaqI polymorphism and diabetes risk. [35] Further studies involving genetic linkage assessment are needed to evaluate the direct effect of these polymorphisms on T2DM; also, the studies should be carried out on a large cohort of population. The major limitation of the current study is its moderately low sample size. While polymorphisms of the VDR gene might play a role in the pathogenesis of T2DM, the non-association of FokI, BsmI and TaqI need to be interpreted considering this limitation. Finally, our data afÞ rms the association of VDR polymorphism in combination of genotypes with risk of T2DM in the north Indian population.
